Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Flu”

2,796 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,796 results

Large-scale testing (Phase 3)Study completedNCT00710866
What this trial is testing

Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity

Who this might be right for
Influenza
British Columbia Centre for Disease Control 262
Large-scale testing (Phase 3)Looking for participantsNCT07357051
What this trial is testing

Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza

Who this might be right for
Respiratory Viral Infection
Joincare Pharmaceutical Group Industry Co., Ltd 177
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Testing effectiveness (Phase 2)Study completedNCT01974895
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 316
Not applicableNot Yet RecruitingNCT07282795
What this trial is testing

Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi 670
Large-scale testing (Phase 3)Study completedNCT02541253
What this trial is testing

Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children

Who this might be right for
Influenza
Green Cross Corporation 543
Post-approval studies (Phase 4)Study completedNCT01355172
What this trial is testing

Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old

Who this might be right for
Influenza
Adimmune Corporation 59
Not applicableLooking for participantsNCT04772170
What this trial is testing

Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies

Who this might be right for
InfluenzaRespiratory VirusCoronavirus
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Post-approval studies (Phase 4)Study completedNCT02246166
What this trial is testing

The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.

Who this might be right for
Common Cold
GlaxoSmithKline 53
Large-scale testing (Phase 3)Study completedNCT02612922
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza

Who this might be right for
Influenza
Romark Laboratories L.C. 325
Early research (Phase 1)Study completedNCT02350751
What this trial is testing

Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults

Who this might be right for
Influenza
MedImmune LLC 94
Early research (Phase 1)UnknownNCT03789539
What this trial is testing

Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu

Who this might be right for
Safety Issues
VA Pharma Limited Liability Company 54
Testing effectiveness (Phase 2)Study completedNCT00985790
What this trial is testing

Immunogenicity and Safety Study of a GlaxoSmithKline Biologicals' Candidate Influenza Vaccine in Healthy Children

Who this might be right for
Influenza
GlaxoSmithKline 599
Not applicableNot Yet RecruitingNCT07430410
What this trial is testing

Clinical Validation of an At-Home Flu A/B and COVID-19 Rapid Test

Who this might be right for
SARS-CoV-2 InfectionInfluenza AInfluenza B
CorDx, Inc. 200
Post-approval studies (Phase 4)UnknownNCT02947217
What this trial is testing

Effect of Influenza Vaccination on IVF Outcomes - IVF

Who this might be right for
Infertility
Center for Human Reproduction 238
Early research (Phase 1)Study completedNCT01175122
What this trial is testing

Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 Influenza

Who this might be right for
Influenza A Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Study completedNCT01959945
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)

Who this might be right for
Influenza
Protein Sciences Corporation 219
Not applicableActive Not RecruitingNCT05160636
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer 999
Post-approval studies (Phase 4)Study completedNCT02215863
What this trial is testing

Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years

Who this might be right for
InfluenzaStreptococcus Pneumoniae
Korea University Guro Hospital 1,195
Next Page